<VariationArchive VariationID="1411238" VariationName="NM_001673.5(ASNS):c.706del (p.Arg236fs)" VariationType="Deletion" Accession="VCV001411238" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2022-03-28" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1343628" VariationID="1411238">
      <GeneList>
        <Gene Symbol="ASNS" FullName="asparagine synthetase (glutamine-hydrolyzing)" GeneID="440" HGNC_ID="HGNC:753" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97851677" stop="97928441" display_start="97851677" display_stop="97928441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="97481428" stop="97501853" display_start="97481428" display_stop="97501853" Strand="-" />
          </Location>
          <OMIM>108370</OMIM>
        </Gene>
        <Gene Symbol="CZ1P-ASNS" FullName="CZ1P-ASNS readthrough" GeneID="107986827" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97852117" stop="97972358" display_start="97852117" display_stop="97972358" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001673.5(ASNS):c.706del (p.Arg236fs)</Name>
      <CanonicalSPDI>NC_000007.14:97858922:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97858923" stop="97858923" display_start="97858923" display_stop="97858923" variantLength="1" positionVCF="97858922" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="97488235" stop="97488235" display_start="97488235" display_stop="97488235" variantLength="1" positionVCF="97488234" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_001673.5(ASNS):c.706del</Name>
        <Name>p.Arg236fs</Name>
      </OtherNameList>
      <ProteinChange>R236fs</ProteinChange>
      <ProteinChange>R153fs</ProteinChange>
      <ProteinChange>R215fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.97858923del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.97858923del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033870.2" sequenceAccession="NG_033870" sequenceVersion="2" change="g.74640del">
            <Expression>NG_033870.2:g.74640del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147989.1" sequenceAccession="NR_147989" sequenceVersion="1" change="n.2335del">
            <Expression>NR_147989.1:n.2335del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178075.2" sequenceAccession="NM_001178075" sequenceVersion="2" change="c.643del">
            <Expression>NM_001178075.2:c.643del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171546.1" sequenceAccession="NP_001171546" sequenceVersion="1" change="p.Arg215fs">
            <Expression>NP_001171546.1:p.Arg215fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178076.2" sequenceAccession="NM_001178076" sequenceVersion="2" change="c.457del">
            <Expression>NM_001178076.2:c.457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171547.1" sequenceAccession="NP_001171547" sequenceVersion="1" change="p.Arg153fs">
            <Expression>NP_001171547.1:p.Arg153fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178077.1" sequenceAccession="NM_001178077" sequenceVersion="1" change="c.457del">
            <Expression>NM_001178077.1:c.457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171548.1" sequenceAccession="NP_001171548" sequenceVersion="1" change="p.Arg153fs">
            <Expression>NP_001171548.1:p.Arg153fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352496.2" sequenceAccession="NM_001352496" sequenceVersion="2" change="c.706del">
            <Expression>NM_001352496.2:c.706del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339425.1" sequenceAccession="NP_001339425" sequenceVersion="1" change="p.Arg236fs">
            <Expression>NP_001339425.1:p.Arg236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001673.5" sequenceAccession="NM_001673" sequenceVersion="5" change="c.706del" MANESelect="true">
            <Expression>NM_001673.5:c.706del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001664.3" sequenceAccession="NP_001664" sequenceVersion="3" change="p.Arg236fs">
            <Expression>NP_001664.3:p.Arg236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133436.3" sequenceAccession="NM_133436" sequenceVersion="3" change="c.706del">
            <Expression>NM_133436.3:c.706del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_597680.2" sequenceAccession="NP_597680" sequenceVersion="2" change="p.Arg236fs">
            <Expression>NP_597680.2:p.Arg236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183356.4" sequenceAccession="NM_183356" sequenceVersion="4" change="c.706del">
            <Expression>NM_183356.4:c.706del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_899199.2" sequenceAccession="NP_899199" sequenceVersion="2" change="p.Arg236fs">
            <Expression>NP_899199.2:p.Arg236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.97488235del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.97488235del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1791584683" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001673.5(ASNS):c.706del (p.Arg236fs) AND not provided" Accession="RCV001942918" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001673.5(ASNS):c.706del (p.Arg236fs) AND Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" Accession="RCV003225983" Version="5">
        <ClassifiedConditionList TraitSetID="12477">
          <ClassifiedCondition DB="MedGen" ID="C3809971">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-03" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-03-28" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27422383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30057589</ID>
        </Citation>
        <DescriptionHistory Dated="2023-05-06">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12477" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18463" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014258" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASNS DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="615574" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Asparagine synthetase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ASNSD</ElementValue>
                <XRef Type="MIM" ID="615574" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17617" />
                <XRef ID="17617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Asparagine synthetase deficiency (ASD) mainly presents as a triad of congenital microcephaly, severe developmental delay, and axial hypotonia followed by spastic quadriplegia. Low cerebrospinal fluid (CSF) asparagine level can help the clinician in differentiating this disorder from others. In most cases age of onset of apnea, excessive irritability, and seizures is soon after birth. Affected individuals typically do not acquire any developmental milestones. Spastic quadriplegia can lead to severe contractures of the limbs and neurogenic scoliosis. Feeding difficulties (gastroesophageal reflux disease, frequent vomiting, swallowing dysfunction, and gastroesophageal incoordination) are a significant problem in most affected individuals. A majority have cortical blindness. MRI findings are nonspecific but may include generalized atrophy and simplified gyral pattern.</Attribute>
                <XRef ID="NBK525916" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30234940</ID>
                <ID Source="BookShelf">NBK525916</ID>
              </Citation>
              <XRef ID="391376" DB="Orphanet" />
              <XRef ID="C3809971" DB="MedGen" />
              <XRef ID="MONDO:0014258" DB="MONDO" />
              <XRef Type="MIM" ID="615574" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7332525" SubmissionDate="2023-11-13" DateLastUpdated="2023-11-20" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="cd03ee42-4086-4cd5-9719-52ec0757c9ec" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922251" DateUpdated="2023-11-20" DateCreated="2023-05-06" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Arg236GlyfsTer8 variant in ASNS was identified by our study, in the compound heterozygous state with a likely pathogenic variant, in one individual with Lennox-Gastaut syndrome, infantile spasms, microcephaly, hypoplasia/partial agenesis of the corpus callosum, delayed myelination, and hypotonia (Broad Institute Rare Genomes Project). Trio genome analysis revealed that this variant was in trans with a likely pathogenic variant. This variant has also been reported in ClinVar (Variation ID: 1411238) and has been interpreted as pathogenic by Invitae. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 361 and leads to a premature termination codon 20 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ASNS gene is an established disease mechanism in autosomal recessive asparagine synthetase deficiency. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive asparagine synthetase deficiency. ACMG/AMP Criteria applied: PVS1, PM2_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001673.5(ASNS):c.706del</Name>
            <Name>p.Arg236fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.14:g.97858923del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014258" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4202469" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="3884128|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002184367" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27422383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30057589</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1411238). This variant has not been reported in the literature in individuals affected with ASNS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg236Glyfs*8) in the ASNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASNS are known to be pathogenic (PMID: 27422383, 30057589).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.97488235del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056343" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="103380948|Orphanet:ORPHA391376" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848661" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely Pathogenic</GermlineClassification>
          <Comment>The p.Arg236GlyfsX8 variant in ASNS has not been reported in the literature in individuals with asparagine synthetase deficiency, but was identified by the Broad Institute Rare Genomes Project in compound heterozygosity with a likely pathogenic variant in a child with Lennox-Gastaut syndrome, infantile spasms, microcephaly, hypoplasia/partial agenesis of the corpus callosum, and hypotonia. This variant was absent from large population studies. It has also been reported in ClinVar (Variation ID 1411238). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 236 and leads to a premature termination codon 8 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ASNS gene is an established disease mechanism in autosomal recessive asparagine synthetase deficiency. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive asparagine synthetase deficiency. ACMG/AMP Criteria applied: PVS1, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001673.5:exon 6A</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.14:g.97858923delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA391376" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7332525" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014258" MappingRef="MONDO">
        <MedGen CUI="C3809971" Name="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056343" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA391376" MappingRef="Orphanet">
        <MedGen CUI="C3809971" Name="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4202469" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

